Revolution Medicines Guards Its Cancer Research and Patients With Abnormal
Revolution Medicines Guards Its Cancer Research and Patients With Abnormal
2 PagesRevolution Medicines enhanced protection of its sensitive cancer research and patient data by implementing Abnormal AI’s human behavior-based threat detection. The AI solution identified and prevented advanced email attacks aimed at stealing intellectual property, allowing scientists and staff to focus on their vital mission. Abnormal’s real-time threat detection and automated response strengthened RevMed’s cybersecurity posture, safeguarding critical research efforts against evolving cyber threats in the highly targeted biotech sector.
